PlainPharmaWatch

CMS Open Payments · Program Year 2024

IBA Proton Therapy, Inc.

IBA Proton Therapy, Inc. reported $24,595.73 across General Payments, Research, and Ownership to 40 physicians and teaching hospitals across 40 transactions.

See the rankings → How this is sourced
$24.6K
All-tracks total
40
Transactions
40
Recipients
−$25.0K
General Payments vs PY2023

IBA Proton Therapy, Inc. reported $24,595.73 across all CMS Open Payments tracks (General + Research + Ownership) to 40 physicians and teaching hospitals in Program Year 2024 - ranking #1499 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $24,595.73, averaging $614.89 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer iba-proton-therapy-inc IBA Proton Therapy, Inc.

$24.6K · #1499/1,925 · 0.0% industry · PY2024

  • TOT $24.6K
  • RANK #1499
  • SHARE 0.0%
  • TXN 40
  • RCP 40
  • CAT 3
  • GEN $24.6K
  • ΔGEN −$25.0K
  • TOP1 8.8%
  • PY 2024

Volume peers

Nearest volume peer: Piedmont Plus Innovation ($24.7K)

Biocodex, Inc.$25.0KForthright Medical-AZ, LLC$24.7KPiedmont Plus Innovation$24.7KIBA Proton Therapy, Inc. (th…$24.6KHelsinn Therapeutics (U.S.),…$24.3K
All-tracks payment totals near IBA Proton Therapy, Inc. (CMS Open Payments PY2024)

IBA Proton Therapy, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

IBA Proton Therapy, Inc.'s CMS-reported General Payments decreased by $25.0K (−50.4%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: IBA PROTON THERAPY, INC.PY2023: IBA PROTON THERAPY, INC.PY2024: IBA Proton Therapy, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$49.6KPY2024$24.6K
PY2023
$49,629.49
PY2024
$24,595.73

What the Data Shows for IBA Proton Therapy, Inc.

$24,595.73: that is what IBA Proton Therapy, Inc. reported in payments to 40 physicians and teaching hospitals during Program Year 2024, spread across 40 transactions ($614.89 per transaction, $614.89 per recipient). The company sits at rank #1499 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Food and Beverage" leads the 3-category general-payment breakdown below at $19.7K (80.0% of General Payments, 37 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 3 types of general payments, IBA Proton Therapy, Inc.'s largest category was "Food and Beverage" at $19.7K - 80.0% of General Payments.

How IBA Proton Therapy, Inc. divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$19.7K2. Honoraria$2.9K3. Consulting Fee$2.0K
Payment Type Amount Transactions
Food and Beverage $19.7K 37
Honoraria $2.9K 2
Consulting Fee $2.0K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $9,752.02 (39.6%) of $24,595.73 in this company's General Payments records across 35 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for IBA Proton Therapy, Inc.

The five named recipients with the highest reported General Payments from this company

Ramesh Rengan$2.2KJing Zeng$2.1KUniversity Of Kansas Hospital$2.0KAlonso Gutierrez$1.9KCharles Simone$1.6K
  1. 1

    Ramesh Rengan

    $2,175.58 across 1 reported transactions

  2. 2

    Jing Zeng

    $2,071.38 across 1 reported transactions

  3. 3

    University Of Kansas Hospital

    $2,000.00 across 1 reported transactions

  4. 4

    Alonso Gutierrez

    $1,860.59 across 1 reported transactions

  5. 5

    Charles Simone

    $1,644.47 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as IBA Proton Therapy, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about IBA Proton Therapy, Inc..

Rattan And Associates

HHI 548

Blue Surgical Llc

HHI 549

Novocure Inc.

HHI 549

Chugai Pharmaceutical Co., Ltd.

HHI 550

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with IBA Proton Therapy, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download IBA Proton Therapy, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.